Taylan Yavuz Bulut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taylan Yavuz Bulut has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Kerem Imrek
Niğde Training and Research Hospital Clinic of Radiology Niğde Türkiye
1 shared publication - Ahmet Şair
AYDIN ADNAN MENDERES UNIVERSITY, SCHOOL OF MEDICINE
1 shared publication - Ayca Tas
Sivas Cumhuriyet Üniversitesi
1 shared publication - Suleyman Demir
Department of Ophthalmology, Adana 5 Ocak State Hospital, Adana, Turkey
1 shared publication - Tugba Agbektas
Sivas Cumhuriyet Üniversitesi
1 shared publication - Yavuz Silig
Sivas Cumhuriyet Üniversitesi
1 shared publication
Latest Publications
- 25 September 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (3) , 571-580
SH3PXD2A LEVELS IN ALZHEIMER’S DISEASE: AN EXPLORATORY STUDY OF A POTENTIAL SYNAPTIC BLOOD BIOMARKER
Objective: Alzheimer’s d isease ( AD) i s a progressive neurodegenerative disorder wi th incompletely understood molecular mechanisms. This study examined plasma SH3 and PX domains 2A (SH3PXD2A) concentrations in patients with AD, as this protein has not previously been directly investigated in AD or other neurodegenerative disorders.Material and Methods: A total of 45 patients w ith A D a nd 4 5 healthy controls were i ncluded. Plasma SH3PXD2A concentrations were measured using a commercial immunoenzymatic assay, and absorbance was recorded at 450 nm using a microplate spectrophotometer. Demographic variables, including age and gender, were also assessed.Results: Gender distribution was comparable between groups; however, participants wi th AD were significantly o lder t han controls. P lasma SH3PXD2A concentrations were significantly hig her in the AD group. In multivariable logistic regression analysis, bo th age an d pl asma SH3PXD2A concentration were independently associated with AD status. ROC analysis indicated moderate discriminatory performance for SH3PXD2A, with an area under the curve of 0.761 (95% CI: 0.657-0.866; p<0.001). A cut-off value of ≥3.120 ng/mL yielded 55.6% sensitivity and 97.8% specificity. The difference in SH3PXD2A concentrations remained significant after adjustment for age.Conclusion: Plasma SH3PXD2A concentrations were elevated in patients with AD and were independently associated with AD status after age adjustment. SH3PXD2A may represent a potential blood-based biomarker candidate in AD. Larger longitudinal studies incorporating detailed clinical characterization and mechanistic investigations are needed to determine its biological and clinical relevance.
- 25 September 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (3) , 571-580
SH3PXD2A LEVELS IN ALZHEIMER’S DISEASE: AN EXPLORATORY STUDY OF A POTENTIAL SYNAPTIC BLOOD BIOMARKER
Objective: Alzheimer’s d isease ( AD) i s a progressive neurodegenerative disorder wi th incompletely understood molecular mechanisms. This study examined plasma SH3 and PX domains 2A (SH3PXD2A) concentrations in patients with AD, as this protein has not previously been directly investigated in AD or other neurodegenerative disorders.Material and Methods: A total of 45 patients w ith A D a nd 4 5 healthy controls were i ncluded. Plasma SH3PXD2A concentrations were measured using a commercial immunoenzymatic assay, and absorbance was recorded at 450 nm using a microplate spectrophotometer. Demographic variables, including age and gender, were also assessed.Results: Gender distribution was comparable between groups; however, participants wi th AD were significantly o lder t han controls. P lasma SH3PXD2A concentrations were significantly hig her in the AD group. In multivariable logistic regression analysis, bo th age an d pl asma SH3PXD2A concentration were independently associated with AD status. ROC analysis indicated moderate discriminatory performance for SH3PXD2A, with an area under the curve of 0.761 (95% CI: 0.657-0.866; p<0.001). A cut-off value of ≥3.120 ng/mL yielded 55.6% sensitivity and 97.8% specificity. The difference in SH3PXD2A concentrations remained significant after adjustment for age.Conclusion: Plasma SH3PXD2A concentrations were elevated in patients with AD and were independently associated with AD status after age adjustment. SH3PXD2A may represent a potential blood-based biomarker candidate in AD. Larger longitudinal studies incorporating detailed clinical characterization and mechanistic investigations are needed to determine its biological and clinical relevance.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
ESAP and Inflammatory Markers in Pure OSA
Objective: Obstructive sleep apnea (OSA) is often accompanied by cardiovascular comorbidities that confound the assessment of independent biomarkers. This study aimed to evaluate the diagnostic utility of the easy sleep apnea predictor (ESAP) test, carotid intima‐media thickness (IMT), and inflammatory blood markers (NLR, MLR, and IG) in a cohort of OSA patients explicitly screened to exclude traditional cardiovascular risk factors. Methods: This cross‐sectional diagnostic study included 50 patients evaluated for sleep‐disordered breathing between September 2023 and January 2024. All patients underwent full‐night polysomnography (PSG). Based on the Apnea–Hypopnea Index (AHI), patients were classified into an OSA group (AHI ≥ 5) and a control group (AHI < 5). The ESAP test (neck encirclement maneuver) was performed in all patients. Carotid IMT was measured via blinded Doppler ultrasonography. Patients with diabetes, hypertension, hyperlipidemia, active smoking, or age > 70 were strictly excluded. Results: The study population was 62% male, with a mean age of 46.58 ± 12.03 years. A statistically significant association was found between male gender and ESAP positivity ( p < 0.001). Furthermore, ESAP positivity was significantly more prevalent in patients with severe OSA compared to mild/moderate forms ( p = 0.033). Conversely, inflammatory markers (neutrophil‐to‐lymphocyte ratio, monocyte‐to‐lymphocyte ratio, and immature granulocytes) and carotid IMT values did not differ significantly between the OSA and control groups, nor did they correlate with pathological vascular involvement in this noncomorbid cohort. Conclusion: In OSA patients free from traditional cardiovascular risk factors, systemic inflammatory markers and subclinical atherosclerosis (IMT) may not be significantly elevated, suggesting that these changes are driven by comorbidities rather than apnea alone. However, the ESAP test remains a robust, practical screening tool for identifying patients at risk of severe OSA.
- 1 January 2026
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2026 (1)
Open AccessESAP and Inflammatory Markers in Pure OSA
Objective: Obstructive sleep apnea (OSA) is often accompanied by cardiovascular comorbidities that confound the assessment of independent biomarkers. This study aimed to evaluate the diagnostic utility of the easy sleep apnea predictor (ESAP) test, carotid intima‐media thickness (IMT), and inflammatory blood markers (NLR, MLR, and IG) in a cohort of OSA patients explicitly screened to exclude traditional cardiovascular risk factors. Methods: This cross‐sectional diagnostic study included 50 patients evaluated for sleep‐disordered breathing between September 2023 and January 2024. All patients underwent full‐night polysomnography (PSG). Based on the Apnea–Hypopnea Index (AHI), patients were classified into an OSA group (AHI ≥ 5) and a control group (AHI < 5). The ESAP test (neck encirclement maneuver) was performed in all patients. Carotid IMT was measured via blinded Doppler ultrasonography. Patients with diabetes, hypertension, hyperlipidemia, active smoking, or age > 70 were strictly excluded. Results: The study population was 62% male, with a mean age of 46.58 ± 12.03 years. A statistically significant association was found between male gender and ESAP positivity ( p < 0.001). Furthermore, ESAP positivity was significantly more prevalent in patients with severe OSA compared to mild/moderate forms ( p = 0.033). Conversely, inflammatory markers (neutrophil‐to‐lymphocyte ratio, monocyte‐to‐lymphocyte ratio, and immature granulocytes) and carotid IMT values did not differ significantly between the OSA and control groups, nor did they correlate with pathological vascular involvement in this noncomorbid cohort. Conclusion: In OSA patients free from traditional cardiovascular risk factors, systemic inflammatory markers and subclinical atherosclerosis (IMT) may not be significantly elevated, suggesting that these changes are driven by comorbidities rather than apnea alone. However, the ESAP test remains a robust, practical screening tool for identifying patients at risk of severe OSA.
- 21 April 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (2) , 1-7
Autonomic dysfunction in obstructive sleep apnea syndrome: a pupillometric measurement study
Purpose It has been suggested that obstructive sleep apnea syndrome (OSAS) is associated with an imbalance in autonomic nervous system (ANS) tone. Pupil size is regarded as a reliable indicator of ANS function. Pupillometry, a straightforward and non-invasive technique, is used to measure both the size and dynamics of the pupil. This study aimed to investigate, through pupillometry, the hypothesis that individuals with OSAS exhibit dysregulation of the autonomic nervous system. Methods In this study, OSAS patients and a control group of healthy individuals were included. OSAS patients were divided into mild, moderate, and severe groups according to their apnea-hypopnea index (AHI) scores. In the study, mild sleep apnea is defined as an AHI between 5 and 14, moderate sleep apnea as an AHI between 15 and 29, and severe sleep apnea as an AHI of 30 or higher. Static and dynamic pupillometric measurements were performed in both groups under scotopic, mesopic, and photopic conditions using a digital infrared pupillometer to evaluate autonomic dysfunction. Results The mean age of the study participants was 52.1 ± 10.4 years. A significant difference was observed between the groups in terms of mean AHI value (p < 0.001). There was no significant difference between the groups for static scotopic, mesopic, photopic pupil measurements (p > 0.05). However, significant differences were found for dynamic pupillary measurements (D1) (p = 0.023) and post-hoc analysis showed a significant difference between the control group and the severe OSAS group (p < 0.001). Correlation analysis revealed a significant correlation between age and AHI (r = 0.269, p = 0.003) and Moreover, a significant negative correlation was observed between AHI and D1 (r = -0.323, p < 0.001). Conclusion In this study on pupillary measurements in OSAS patients, no significant difference was found in static pupillary responses in OSAS patients, whereas dynamic pupillary responses were found to be significantly impaired in severe OSAS. The significant impairment in severe OSAS suggests autonomic dysfunction due to hypoxia-induced neuronal damage. In conclusion, pupillometry may be a simple, noninvasive approach to detect ANS dysfunction in OSAS patients.
- 21 April 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (2) , 1-7
Autonomic dysfunction in obstructive sleep apnea syndrome: a pupillometric measurement study
Purpose It has been suggested that obstructive sleep apnea syndrome (OSAS) is associated with an imbalance in autonomic nervous system (ANS) tone. Pupil size is regarded as a reliable indicator of ANS function. Pupillometry, a straightforward and non-invasive technique, is used to measure both the size and dynamics of the pupil. This study aimed to investigate, through pupillometry, the hypothesis that individuals with OSAS exhibit dysregulation of the autonomic nervous system. Methods In this study, OSAS patients and a control group of healthy individuals were included. OSAS patients were divided into mild, moderate, and severe groups according to their apnea-hypopnea index (AHI) scores. In the study, mild sleep apnea is defined as an AHI between 5 and 14, moderate sleep apnea as an AHI between 15 and 29, and severe sleep apnea as an AHI of 30 or higher. Static and dynamic pupillometric measurements were performed in both groups under scotopic, mesopic, and photopic conditions using a digital infrared pupillometer to evaluate autonomic dysfunction. Results The mean age of the study participants was 52.1 ± 10.4 years. A significant difference was observed between the groups in terms of mean AHI value (p < 0.001). There was no significant difference between the groups for static scotopic, mesopic, photopic pupil measurements (p > 0.05). However, significant differences were found for dynamic pupillary measurements (D1) (p = 0.023) and post-hoc analysis showed a significant difference between the control group and the severe OSAS group (p < 0.001). Correlation analysis revealed a significant correlation between age and AHI (r = 0.269, p = 0.003) and Moreover, a significant negative correlation was observed between AHI and D1 (r = -0.323, p < 0.001). Conclusion In this study on pupillary measurements in OSAS patients, no significant difference was found in static pupillary responses in OSAS patients, whereas dynamic pupillary responses were found to be significantly impaired in severe OSAS. The significant impairment in severe OSAS suggests autonomic dysfunction due to hypoxia-induced neuronal damage. In conclusion, pupillometry may be a simple, noninvasive approach to detect ANS dysfunction in OSAS patients.
- 27 December 2023
- Published by Acil Tip Uzmanlari Dernegi in Eurasian Journal of Critical Care
- Vol. 5 (3) , 102-106
EXAMINATION OF NEUTROPHIL/LYMPHOCYTE (NLR), MONOCYTE/LYMPHOCYTE (MLR), AND PLATELET/LYMPHOCYTE (PLR) RATIOS BETWEEN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA
Background: The present study aims to investigate whether proinflammatory marker ratios in whole blood differ in these two dementia diseases. Materials and Methods: This study will involve Alzheimer's disease (AD) and vascular dementia (VaD) patients who were treated as outpatients in the outpatient clinic and inpatients in the ward of the Neurology Department of Adnan Menderes University Hospital. The patients’ diagnoses will be scanned in the hospital information system. The admission blood results of patients who presented between January 2018 and September 2020 will be included, and the patients’ hemogram results will be scanned retrospectively. Neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in the hemogram results will be calculated and recorded. Results: In the AD-VaD comparison of the patients participating in the study, a significant difference was identified between the variability of platelet/lymphocyte (PLR) and NLRs (NLR) (p<0.001). Moreover, a significant difference was found between the mean ages of patients with vascular dementia and those with Alzheimer's dementia (p<0.0001). Conclusion: While proinflammatory markers obtained secondary to inflammation are significant in AD since it is a chronic and progressive process, the use of these markers is limited due to the gradual course after an acute event in vascular dementia. Furthermore, there is a need for additional studies on peripheral blood cells to identify the potential prodromal biomarkers of AD.
- 27 December 2023
- Published by Acil Tip Uzmanlari Dernegi in Eurasian Journal of Critical Care
- Vol. 5 (3) , 102-106
EXAMINATION OF NEUTROPHIL/LYMPHOCYTE (NLR), MONOCYTE/LYMPHOCYTE (MLR), AND PLATELET/LYMPHOCYTE (PLR) RATIOS BETWEEN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA
Background: The present study aims to investigate whether proinflammatory marker ratios in whole blood differ in these two dementia diseases. Materials and Methods: This study will involve Alzheimer's disease (AD) and vascular dementia (VaD) patients who were treated as outpatients in the outpatient clinic and inpatients in the ward of the Neurology Department of Adnan Menderes University Hospital. The patients’ diagnoses will be scanned in the hospital information system. The admission blood results of patients who presented between January 2018 and September 2020 will be included, and the patients’ hemogram results will be scanned retrospectively. Neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in the hemogram results will be calculated and recorded. Results: In the AD-VaD comparison of the patients participating in the study, a significant difference was identified between the variability of platelet/lymphocyte (PLR) and NLRs (NLR) (p<0.001). Moreover, a significant difference was found between the mean ages of patients with vascular dementia and those with Alzheimer's dementia (p<0.0001). Conclusion: While proinflammatory markers obtained secondary to inflammation are significant in AD since it is a chronic and progressive process, the use of these markers is limited due to the gradual course after an acute event in vascular dementia. Furthermore, there is a need for additional studies on peripheral blood cells to identify the potential prodromal biomarkers of AD.